Literature DB >> 12723069

Synchronization of Bos indicus x Bos taurus cows for timed artificial insemination using gonadotropin-releasing hormone plus prostaglandin F2alpha in combination with melengestrol acetate.

E A Hiers1, C R Barthle, M K V Dahms, G E Portillo, G A Bridges, D O Rae, W W Thatcher, J V Yelich.   

Abstract

Nonlactating Bos indicus x Bos taurus cows were used in three herds to determine the efficacy of different PGF2alpha treatments in combination with GnRH and melengestrol acetate (MGA) for a timed artificial insemination protocol. The start of the experiment was designated as d 0, at which time cows were assigned a body condition score and received 100 microg of GnRH. Cows were fed MGA (0.5 x mg x cow(-1) x d(-1)) on d 1 to 7. On d 7, cows received either a single injection of PGF2alpha (Lutalyse sterile solution; 25 mg; n = 297), a single injection of cloprostenol sodium (Estrumate; 500 microg; n = 297), or half the recommended dose of PGF2alpha (12.5 mg; n = 275) on d 7 and 8. On d 10, all cows were artificially inseminated and received 100 microg of GnRH. Pregnancy rates to the timed artificial insemination (39%) were not affected by treatment, herd, or treatment x herd. There was an effect (P < 0.01) of artificial insemination sire on timed artificial insemination pregnancy rate for one herd, but not the other two herds. Herd influenced (P < 0.05) 30-d pregnancy rates, but there were no treatment or treatment x herd effects as 72.3% of the cows became pregnant during the first 30 d of the breeding season. Results indicate that the type of PGF2alpha treatment administered 7 d after GnRH did not influence timed artificial insemination pregnancy rates in nonlactating Bos indicus x Bos taurus cows.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723069     DOI: 10.2527/2003.814830x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  1 in total

Review 1.  Reproductive management in dairy cows - the future.

Authors:  Mark A Crowe; Miel Hostens; Geert Opsomer
Journal:  Ir Vet J       Date:  2018-01-08       Impact factor: 2.146

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.